Important Notes
This annual report summary is derived from the full annual report. To fully understand the company's operational results, financial status, and future development plans, investors should carefully read the full annual report published in designated media by the China Securities Regulatory Commission. All directors attended the board meeting to review this report. Tianjian Accounting Firm (Special General Partnership) provided a standard unqualified audit opinion on this year's financial report. Non-standard audit opinion prompt: □ Applicable ☑ Not applicable. The company was unprofitable at the time of listing and remains unprofitable. □ Applicable ☑ Not applicable. The profit distribution plan or capital reserve transfer plan reviewed by the board during the reporting period is ☑ Applicable □ Not applicable. The profit distribution plan approved by the board is: based on 2,230,085,000 shares, a cash dividend of 1.73 yuan (tax included) per 10 shares will be distributed to all shareholders, with no bonus shares (tax included), and no shares will be transferred from capital reserves to shareholders. The board resolution on the preferred stock profit distribution plan for this reporting period is □ Applicable ☑ Not applicable.
Company Overview
- Company Profile
- Stock Abbreviation: Chuaning Bio
- Stock Code: 301301
- Stock Exchange: Shenzhen Stock Exchange
- Contact Person: Gu Xiang
- Contact Information:
- Office Address: No. 1 Gongchen Road, Yining Park, Economic Development Zone, Horgos City, Ili Kazakh Autonomous Prefecture, Xinjiang
- Fax: 0999-8077667
- Phone: 0999-8077567
- Email: ir@klcnsw.com